Results 121 to 130 of about 49,389 (200)

Distinct ocular microvascular alterations in Alzheimer's disease and cerebral small vessel disease

Alzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract INTRODUCTION While both Alzheimer's disease (AD) and cerebral small vessel disease (CSVD) involve vascular dysfunction, the ocular microvascular differences between them remain largely underinvestigated. METHODS This cross‐sectional study included 650 participants (149 AD, 276 CSVD, and 225 cognitively unimpaired individuals).
Ziyi Zhang, Le Cao, Peng Liu, Shiyun Yang, Yuying Yan, William Robert Kwapong, Ying He, Mingyuan Yang, Hang Wang, Youjie Wang, Zijuan Feng, Jingyu Zhou, Ming Liu, Peng Lei, Bo Wu, Shuting Zhang   +15 more
wiley   +1 more source

Anterior chamber flare and central macular thickness after trabeculectomy versus after phacoemulsification. [PDF]

Acta Ophthalmol
Ahmed Y, Erichsen JH, Ahmadzadeh A, Holm LM, Kessel L, Bach-Holm D.   +5 more
europepmc   +1 more source

Retinal microvascular changes are related to indicators of glymphatic dysfunction and small vessel disease in frontotemporal dementia

Alzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract INTRODUCTION Retinal vascular alterations have been associated with cerebral small vessel disease (SVD) in frontotemporal dementia (FTD), but their relationship with magnetic resonance imaging (MRI)‐derived glymphatic‐related diffusion markers remains unclear.
William Robert Kwapong, Yufei Chen, Xu Chen, Jiahui Hou, Hua Lu, Yuxuan Xu, Qianqian He, Yuan Gao, Ruoyu Jiao, Liyong Wu, Xuxiang Zhang, Min Chu   +11 more
wiley   +1 more source

Association between anti-TNF and NSAID therapy and choroidal and macular thickness in ankylosing spondylitis: an OCT-based study. [PDF]

BMC Ophthalmol
Gök ZE, Altuner MŞ, Mutlu K.
europepmc   +1 more source

Physical Activity Is Associated With Macular Thickness: A Multi-Cohort Observational Study. [PDF]

Invest Ophthalmol Vis Sci, 2023
Berry EC, Marshall HN, Mullany S, Torres SD, Schmidt J, Thomson D, Knight LSW, Hollitt GL, Qassim A, Ridge B, Schulz A, Hassall MM, Nguyen TT, Lake S, Mills RA, Agar A, Galanopoulos A, Landers J, Healey PR, Graham SL, Hewitt AW, MacGregor S, Casson RJ, Siggs OM, Craig JE.   +24 more
europepmc   +1 more source

Drug Delivery With Metal–Organic Frameworks

Angewandte Chemie Novit, Volume 2, Issue 3, September 2026.
Metal–organic frameworks (MOFs) have recently entered human clinical trials for cancer radiotherapy, highlighting both the maturity and potential of MOFs as platforms for drug delivery. This minireview introduces the principles of MOF‐based drug delivery and discusses key opportunities and design challenges that will shape the next generation of these ...
Nathalie W. Tarabay, Alexander S. Evtushenko, Mohammad Reza Alizadeh Kiapi, Xu Chen, Katia Caamaño, Ljiljana Fruk, David Fairen‐Jimenez   +6 more
wiley   +1 more source

Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy. [PDF]

Clin Ophthalmol
Wei Q, Wang W, Qiu Q.
europepmc   +1 more source

Advanced nanotherapeutics for combating ocular infections: Rational design, antimicrobial mechanisms, and therapeutic breakthroughs

BMEMat, Volume 4, Issue 3, September 2026.
Nanomaterials revolutionize ocular infection treatment by enabling targeted drug delivery and enhanced antimicrobial efficacy against resistant pathogens. This review systematically explores their rational design, multimodal mechanisms, and translational potential for next‐generation anti‐infective therapies.
Yujia Liu, Xuetian Wen, Yue Tan, Rui Zeng, Yijuan Zhang, Tong Lin, Lan Gong, Zichao Luo   +7 more
wiley   +1 more source

Peripheral instability gradient in macular thickness measurements across five optical coherence tomography systems: a prospective cross-sectional study of inter-device agreement and clinical monitoring risk. [PDF]

BMC Med Imaging
Akkan F, Gorgun E.
europepmc   +1 more source

Normative Data for Macular Thickness and Volume for Optical Coherence Tomography in a Diabetic Population without Maculopathies. [PDF]

J Clin Med, 2023
Arruabarrena C, Rodríguez-Miguel A, de Aragón-Gómez F, Escámez P, Rosado I, Teus MA.   +5 more
europepmc   +1 more source